NO951750L - Renset "nontypable" Haemophilus influenzae P5 protein som en vaksine for "nontypable" Haemophilus influenzae stamme - Google Patents

Renset "nontypable" Haemophilus influenzae P5 protein som en vaksine for "nontypable" Haemophilus influenzae stamme

Info

Publication number
NO951750L
NO951750L NO951750A NO951750A NO951750L NO 951750 L NO951750 L NO 951750L NO 951750 A NO951750 A NO 951750A NO 951750 A NO951750 A NO 951750A NO 951750 L NO951750 L NO 951750L
Authority
NO
Norway
Prior art keywords
haemophilus influenzae
nontypable
protein
vaccine
purified
Prior art date
Application number
NO951750A
Other languages
English (en)
Norwegian (no)
Other versions
NO951750D0 (no
Inventor
Gary W Zlotnick
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NO951750D0 publication Critical patent/NO951750D0/no
Publication of NO951750L publication Critical patent/NO951750L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/807—Hapten conjugated with peptide or protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO951750A 1994-05-05 1995-05-04 Renset "nontypable" Haemophilus influenzae P5 protein som en vaksine for "nontypable" Haemophilus influenzae stamme NO951750L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/210,394 US5770213A (en) 1994-05-05 1994-05-05 Purified nontypable haemophilus influenzae P5 protein as a vaccine for nontypable haemophilus influenzae infection

Publications (2)

Publication Number Publication Date
NO951750D0 NO951750D0 (no) 1995-05-04
NO951750L true NO951750L (no) 1995-11-06

Family

ID=22782738

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951750A NO951750L (no) 1994-05-05 1995-05-04 Renset "nontypable" Haemophilus influenzae P5 protein som en vaksine for "nontypable" Haemophilus influenzae stamme

Country Status (14)

Country Link
US (2) US5770213A (fr)
EP (1) EP0680765B1 (fr)
JP (2) JP4236215B2 (fr)
KR (1) KR100366482B1 (fr)
AT (1) ATE356633T1 (fr)
AU (1) AU704882B2 (fr)
CA (1) CA2148563C (fr)
DE (1) DE69535422T2 (fr)
DK (1) DK0680765T3 (fr)
ES (1) ES2282992T3 (fr)
FI (1) FI120149B (fr)
IL (1) IL113595A (fr)
NO (1) NO951750L (fr)
PT (1) PT680765E (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002089839A1 (fr) * 2001-05-03 2002-11-14 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Immunisation intranasale par un lipooligosaccharide detoxifie provenant d'un haemophilus influenzae ou d'un moraxella catarrhalis non typable
US20040126381A1 (en) * 1996-04-23 2004-07-01 Xin-Xing Gu Intranasal immunization with detoxified lipooligosaccharide from nontypeable haemophilus influenzae or moraxella
GB9812613D0 (en) * 1998-06-11 1998-08-12 Smithkline Beecham Biolog Vaccine
US6974581B1 (en) * 1998-12-15 2005-12-13 Aventis Pasteur Limited Multi-component vaccine comprising at least two antigens from haemophilus influenzae to protect against disease
GB9904183D0 (en) * 1999-02-24 1999-04-14 Smithkline Beecham Biolog Novel compounds
US7101989B1 (en) 1999-07-09 2006-09-05 University Of North Carolina At Chapel Hill DsrA protein and polynucleotides encoding the same
GB0025486D0 (en) * 2000-10-17 2000-11-29 Smithkline Beecham Biolog Novel compounds
AU2003250673A1 (en) * 2002-07-24 2004-02-09 Id Biomedical Corporation Polypeptides of nontypeable haemophilus influenzae
US7709001B2 (en) 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
IL308456A (en) 2005-04-08 2024-01-01 Wyeth Llc A multivalent pneumomuroral protein-polysaccharide conjugate preparation
AU2009294321B2 (en) 2008-09-17 2014-02-13 Hunter Immunology Pty Ltd Non-typeable Haemophilus influenzae vaccines and their uses
KR102409709B1 (ko) 2021-11-30 2022-06-16 박정민 케이블 접속장치

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300632A (en) * 1986-11-18 1994-04-05 Research Foundation Of State University Of New York Method for purifying an outer membrane protein of Haemophilus influenzae
US5098997A (en) * 1987-12-11 1992-03-24 Praxis Biologics, Inc. Vaccines for Haemophilus influenzae
US5098987A (en) * 1989-07-13 1992-03-24 The United States Of America As Represented By The Secretary Of The Air Force Crosslinkable rigid-rod benzobisazole polymer
ES2185658T3 (es) 1993-05-18 2003-05-01 Univ Ohio State Res Found Vacuna para la otitis media.

Also Published As

Publication number Publication date
PT680765E (pt) 2007-05-31
FI120149B (fi) 2009-07-15
FI952144A (fi) 1995-11-06
KR100366482B1 (ko) 2003-08-02
DE69535422T2 (de) 2007-12-13
FI952144A0 (fi) 1995-05-04
EP0680765B1 (fr) 2007-03-14
CA2148563A1 (fr) 1995-11-06
DK0680765T3 (da) 2007-07-02
EP0680765A1 (fr) 1995-11-08
USRE37741E1 (en) 2002-06-11
ATE356633T1 (de) 2007-04-15
CA2148563C (fr) 2008-10-07
IL113595A0 (en) 1995-08-31
ES2282992T3 (es) 2007-10-16
DE69535422D1 (de) 2007-04-26
AU1781495A (en) 1995-11-16
JP4236215B2 (ja) 2009-03-11
JP2009051859A (ja) 2009-03-12
AU704882B2 (en) 1999-05-06
IL113595A (en) 2001-05-20
JPH08337598A (ja) 1996-12-24
NO951750D0 (no) 1995-05-04
KR950031108A (ko) 1995-12-18
US5770213A (en) 1998-06-23

Similar Documents

Publication Publication Date Title
WO1998008542A3 (fr) Composes et procedes destines au traitement et au diagnostic d'infections mycobacteriennes
AU6236396A (en) Omp26 antigen from haemophilus influenzae
AU657487B2 (en) Nucleotide sequence coding for an outer membrane protein from neisseria meningitidis and use of said protein in vaccine preparations
DE69333802D1 (de) Äusseres membranprotein von haemophilus
GB2302329B (en) Yeast strains
AP2000001886A0 (en) Group B streptococcus antigens.
GR3029477T3 (en) Vaccine against gram-negative bacterial infections
CA2051808A1 (fr) Methode d'isolement et de purification des proteines receptrices de la transferrine et de la lactoferrine a partir de bacteries et preparation de vaccins contenant ces globulines
NO951750L (no) Renset "nontypable" Haemophilus influenzae P5 protein som en vaksine for "nontypable" Haemophilus influenzae stamme
AU1915995A (en) Active immunization using a siderophore receptor protein
IL125420A0 (en) Expression of group b neisseria meningitidis outer membrane (mb3) protein from yeast and vaccines containing said protein
AU2967595A (en) Anti-protozoan methods and materials
WO1997005899A3 (fr) Nouveaux vaccins et nouvelles compositions pharmaceutiques utilisant des vesicules de membrane de micro-organismes et leurs procedes d'elaboration
AU589552B2 (en) Vaccine and serum for endotoxin associated disease and method of preparing same as well as to methods of immunization and treatment of such disease and to a detoxified endotoxin and bacterial mutant
ATE272648T1 (de) Glycokonjugate von 20(s)-camptothecin
DE68915046D1 (de) Haemophilus influenzae Typ B Polysaccharid-Aussermembranprotein-Konjugat als Impfstoff.
DK0565590T3 (da) Adhesin-oligosaccharid-konjugatvaccine mod Haemophilus influenzae
FI960308A0 (fi) Menetelmä Haemophilus influenzae, tyyppi b:n P2-proteiinien ilmentämiseksi ja puhdistamiseksi
AU601415B2 (en) A process for the purification, solubilization and/or detoxification of protein antigens of bacteria of the bordetella genus using a carbonate buffer and an acellular anti-whooping cough vaccine
AU2548597A (en) Antibodies against avirulence/pathogenicity proteins of plant pathogens
AU603794C (en) Affinity chromatography method for the separation and purification of protein antigens of the bacteria of the bordetella genus
ATE206619T1 (de) Komplex aus antigen und zellbestandteil, verfahren zur dessen herstellung und therapeutische verwendungen